Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.120 | 3 | 119993874 | intron variant | A/G | snv | 0.28 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.120 | 3 | 119993874 | intron variant | A/G | snv | 0.28 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.120 | 3 | 119993874 | intron variant | A/G | snv | 0.28 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.120 | 3 | 119993874 | intron variant | A/G | snv | 0.28 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 3 | 119931941 | intron variant | T/C | snv | 0.54 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.120 | 3 | 119931941 | intron variant | T/C | snv | 0.54 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 3 | 119922595 | intron variant | A/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 3 | 119839004 | intron variant | A/T | snv | 0.24 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.925 | 0.120 | 3 | 119841759 | intron variant | T/A;C | snv |
|
0.800 | 1.000 | 2 | 2013 | 2017 | |||||||||
|
0.925 | 0.120 | 3 | 119841759 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.925 | 0.120 | 3 | 119841759 | intron variant | T/A;C | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 3 | 119841759 | intron variant | T/A;C | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 0.040 | 3 | 119891946 | intron variant | C/T | snv | 0.54 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2010 | 2010 | |||||||
|
0.925 | 0.120 | 3 | 120056300 | intron variant | C/T | snv | 0.28 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.925 | 0.120 | 3 | 120056300 | intron variant | C/T | snv | 0.28 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.882 | 0.040 | 3 | 119974764 | intron variant | T/C | snv | 0.22 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.040 | 3 | 119974764 | intron variant | T/C | snv | 0.22 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.040 | 3 | 119974764 | intron variant | T/C | snv | 0.22 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.790 | 0.280 | 3 | 119912967 | intron variant | A/G | snv | 0.54 |
|
Nervous System Diseases | 0.050 | 0.800 | 5 | 2005 | 2013 | |||||||
|
0.790 | 0.280 | 3 | 119912967 | intron variant | A/G | snv | 0.54 |
|
Nervous System Diseases; Mental Disorders | 0.020 | 1.000 | 2 | 2013 | 2015 | |||||||
|
0.790 | 0.280 | 3 | 119912967 | intron variant | A/G | snv | 0.54 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.790 | 0.280 | 3 | 119912967 | intron variant | A/G | snv | 0.54 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.790 | 0.280 | 3 | 119912967 | intron variant | A/G | snv | 0.54 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.790 | 0.280 | 3 | 119912967 | intron variant | A/G | snv | 0.54 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.790 | 0.280 | 3 | 119912967 | intron variant | A/G | snv | 0.54 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 |